Found: 29
Select item for more details and to access through your institution.
Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.
- Published in:
- Contrast Media & Molecular Imaging, 2018, p. 1, doi. 10.1155/2018/6930425
- By:
- Publication type:
- Article
High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.
- Published in:
- Contrast Media & Molecular Imaging, 2017, v. 2017, p. 1, doi. 10.1155/2017/6873684
- By:
- Publication type:
- Article
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 5993, doi. 10.3390/molecules25245993
- By:
- Publication type:
- Article
The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a <sup>68</sup>Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin.
- Published in:
- Molecules, 2014, v. 19, n. 7, p. 10455, doi. 10.3390/molecules190710455
- By:
- Publication type:
- Article
Synthesis of <sup>11</sup>C‐labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [<sup>11</sup>C]CO.
- Published in:
- ChemistryOpen, 2016, v. 5, n. 6, p. 566, doi. 10.1002/open.201600091
- By:
- Publication type:
- Article
Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-43145-2
- By:
- Publication type:
- Article
Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36827-w
- By:
- Publication type:
- Article
Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 1972, doi. 10.3390/ijms21061972
- By:
- Publication type:
- Article
Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1080, doi. 10.3390/ijms20051080
- By:
- Publication type:
- Article
Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 4, p. 1209
- By:
- Publication type:
- Article
Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 6, p. 1765, doi. 10.3892/ijo.2017.4152
- By:
- Publication type:
- Article
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with <sup>99m</sup>Tc using a peptide-based cysteine-containing chelator.
- Published in:
- International Journal of Oncology, 2016, v. 49, n. 6, p. 2285, doi. 10.3892/ijo.2016.3721
- By:
- Publication type:
- Article
Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 5, p. 2124, doi. 10.3892/ijo.2016.3429
- By:
- Publication type:
- Article
PET imaging of epidermal growth factor receptor expression in tumours using <sup>89</sup>Zr-labelled ZEGFR:2377 affibody molecules.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 4, p. 1325, doi. 10.3892/ijo.2016.3369
- By:
- Publication type:
- Article
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid--Mediated Pretargeting: In Vivo Proof of Principle.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 7, p. 1092, doi. 10.2967/jnumed.118.208348
- By:
- Publication type:
- Article
Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 93, doi. 10.2967/jnumed.117.197202
- By:
- Publication type:
- Article
Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretarge.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 3, p. 431, doi. 10.2967/jnumed.115.162248
- By:
- Publication type:
- Article
Increase in negative charge of <sup>68</sup>Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54149-3
- By:
- Publication type:
- Article
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52914-y
- By:
- Publication type:
- Article
Imaging of fibrogenesis in the liver by [<sup>18</sup>F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00210-6
- By:
- Publication type:
- Article
In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct.
- Published in:
- Scientific Reports, 2017, p. 43118, doi. 10.1038/srep43118
- By:
- Publication type:
- Article
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1371, doi. 10.3390/cancers11091371
- By:
- Publication type:
- Article
Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-Z<sub>EGFR:2377</sub>.
- Published in:
- Oncology Reports, 2019, v. 41, n. 1, p. 534, doi. 10.3892/or.2018.6792
- By:
- Publication type:
- Article
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of <sup>99m</sup>Tc-labeled anti-EGFR affibody molecules.
- Published in:
- Amino Acids, 2018, v. 50, n. 8, p. 981, doi. 10.1007/s00726-018-2571-1
- By:
- Publication type:
- Article
Evaluation of Tc-Z-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression.
- Published in:
- Amino Acids, 2015, v. 47, n. 2, p. 303, doi. 10.1007/s00726-014-1859-z
- By:
- Publication type:
- Article
Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist <sup>177</sup>Lu‐DOTAGA‐PEG<sub>2</sub>‐RM26.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3347, doi. 10.1002/ijc.32401
- By:
- Publication type:
- Article
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 7, p. 614, doi. 10.3390/pharmaceutics12070614
- By:
- Publication type:
- Article
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 8, p. 380, doi. 10.3390/pharmaceutics11080380
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 7, p. 358, doi. 10.3390/pharmaceutics11070358
- By:
- Publication type:
- Article